Balsm Alofoq Medical Company (TADAWUL:9620)

TADAWUL:9620 Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	18.1	18.24	3.68	5.74
Cash & Short-Term Investments	18.1	18.24	3.68	5.74
Cash Growth	239.56%	396.05%	-35.90%	-
Accounts Receivable	0.39	0.34	0.3	0.3
Other Receivables	0.28	0.28	0.04	0.02
Receivables	0.66	0.62	0.34	0.32
Inventory	3.27	1.72	1.5	0.68
Prepaid Expenses	0.04	0.03	-	-
Other Current Assets	0.6	0.59	0.28	0.66
Total Current Assets	22.69	21.2	5.8	7.39
Property, Plant & Equipment	11.64	12.08	12.86	7.51
Total Assets	34.33	33.28	18.66	14.9
Accounts Payable	0.93	0.27	0.34	0.44
Accrued Expenses	-	0.79	0.84	0.62
Current Portion of Leases	0.22	0.31	0.23	0.5
Current Income Taxes Payable	0.12	0.26	0.1	0.12
Other Current Liabilities	-	-	0.01	2.69
Total Current Liabilities	1.28	1.64	1.52	4.37
Long-Term Leases	1.48	1.5	1.69	2.13
Pension & Post-Retirement Benefits	1.31	1.23	1.06	1.04
Total Liabilities	4.07	4.36	4.27	7.54
Common Stock	12.5	12.5	10	4.9
Additional Paid-In Capital	10.15	10.15	-	-
Retained Earnings	7.61	6.27	4.39	2.46
Shareholders' Equity	30.26	28.92	14.39	7.36
Total Liabilities & Equity	34.33	33.28	18.66	14.9
Total Debt	1.7	1.8	1.93	2.62
Net Cash (Debt)	16.4	16.44	1.75	3.11
Net Cash Growth	394.11%	838.03%	-43.71%	-
Net Cash Per Share	14.31	16.10	2.38	-
Filing Date Shares Outstanding	1.25	1.25	0.74	-
Total Common Shares Outstanding	1.25	1.25	0.74	-
Working Capital	21.41	19.56	4.28	3.02
Book Value Per Share	24.21	23.13	19.43	-
Tangible Book Value	30.26	28.92	14.39	7.36
Tangible Book Value Per Share	24.21	23.13	19.43	-
Land	5.13	5.13	5.13	-
Buildings	3.36	3.36	3.36	-
Machinery	6.75	6.46	6.27	6.17
Leasehold Improvements	1.14	1.13	1.11	2.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.